Cardiac sympathetic denervation, as documented on 123I-metaiodobenzylguanidine (MIBG)
myocardial scintigraphy, is relatively sensitive and specific for distinguishing Parkinson's …

Dementia with Lewy Bodies (DLB) is a common form of cognitive neurodegenerative
disease. Only one third of patients are correctly diagnosed due to the clinical similarity …

Introduction Operationalized research criteria for mild cognitive impairment with Lewy
bodies (MCI‐LB) were published in 2020. The aim of this systematic review and meta …

Background This study aimed to identify cases of potential prodromal DLB in very late-onset
schizophrenia-like psychosis (VLOSLP), using indicative biomarkers of dementia with Lewy …

This pragmatic review synthesises the current understanding of prodromal dementia with
Lewy bodies (pDLB) and prodromal Alzheimer's disease (pAD), including clinical …

Research criteria for the diagnosis of prodromal dementia with Lewy bodies (DLB) include
three clinical subtypes: mild cognitive impairment with Lewy bodies (MCI‐LB), delirium …

BackgroundBlood biomarkers of Alzheimer's disease (AD) may allow for the early detection
of AD pathology in mild cognitive impairment (MCI) due to AD (MCI-AD) and as a co …

Background Alzheimer's disease (AD) co‐pathology is common in dementia with Lewy
bodies and is associated with increased decline. Plasma pTau181 is a blood‐based …

Introduction Dopaminergic scintigraphic imaging is a cornerstone to support the diagnosis in
dementia with Lewy bodies. To clarify the current state of knowledge on this imaging …

Background and Objectives Retrospective studies indicate that dementia with Lewy bodies
(DLB) may be preceded by a mild cognitive impairment (MCI) prodrome. Research criteria …